Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa.

Tan MA, Lagamayo MWD, Alejandro GJD, An SSA.

Molecules. 2019 Nov 14;24(22). pii: E4112. doi: 10.3390/molecules24224112.

2.

Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer's disease.

Meng X, Li T, Wang X, Lv X, Sun Z, Zhang J, Su F, Kang S, Kim S, An SSA, Yu X, Zhang C, Wang H.

Alzheimers Res Ther. 2019 Oct 25;11(1):89. doi: 10.1186/s13195-019-0535-7.

3.

Deletion of the microRNA-degrading nuclease, translin/trax, prevents pathogenic vascular stiffness.

Tuday E, Nomura Y, Ruhela D, Nakano M, Fu X, Shah A, Roman B, Yamaguchi A, An SS, Steenbergen C, Baraban JM, Berkowitz DE, Das S.

Am J Physiol Heart Circ Physiol. 2019 Nov 1;317(5):H1116-H1124. doi: 10.1152/ajpheart.00153.2019. Epub 2019 Oct 18.

PMID:
31625778
4.

Novel amyloid precursor protein mutation, Val669Leu ("Seoul APP"), in a Korean patient with early-onset Alzheimer's disease.

Bagyinszky E, Kang MJ, Van Giau V, Shim K, Pyun JM, Suh J, An SSA, Kim S.

Neurobiol Aging. 2019 Aug 31. pii: S0197-4580(19)30305-7. doi: 10.1016/j.neurobiolaging.2019.08.026. [Epub ahead of print]

PMID:
31623876
5.

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease.

Giau VV, Bagyinszky E, Youn YC, An SSA, Kim S.

Int J Mol Sci. 2019 Sep 25;20(19). pii: E4757. doi: 10.3390/ijms20194757.

6.

Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome.

Giau VV, Bagyinszky E, Youn YC, An SSA, Kim SY.

Int J Mol Sci. 2019 Sep 3;20(17). pii: E4298. doi: 10.3390/ijms20174298. Review.

7.

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment.

Giau VV, Bagyinszky E, An SSA.

Int J Mol Sci. 2019 Aug 25;20(17). pii: E4149. doi: 10.3390/ijms20174149. Review.

8.

Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt-Jakob disease.

Bagyinszky E, Yang Y, Giau VV, Youn YC, An SSA, Kim S.

Clin Interv Aging. 2019 Aug 2;14:1387-1397. doi: 10.2147/CIA.S210909. eCollection 2019.

9.

APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample.

Choi KY, Lee JJ, Gunasekaran TI, Kang S, Lee W, Jeong J, Lim HJ, Zhang X, Zhu C, Won SY, Choi YY, Seo EH, Lee SC, Gim J, Chung JY, Chong A, Byun MS, Seo S, Ko PW, Han JW, McLean C, Farrell J, Lunetta KL, Miyashita A, Hara N, Won S, Choi SM, Ha JM, Jeong JH, Kuwano R, Song MK, An SSA, Lee YM, Park KW, Lee HW, Choi SH, Rhee S, Song WK, Lee JS, Mayeux R, Haines JL, Pericak-Vance MA, Choo ILH, Nho K, Kim KW, Lee DY, Kim S, Kim BC, Kim H, Jun GR, Schellenberg GD, Ikeuchi T, Farrer LA, Lee KH, Neuroimaging Initative AD.

J Clin Med. 2019 Aug 16;8(8). pii: E1236. doi: 10.3390/jcm8081236.

10.

Early-onset Alzheimer's disease patient with prion (PRNP) p.Val180Ile mutation.

Bagyinszky E, Kang MJ, Pyun J, Giau VV, An SSA, Kim S.

Neuropsychiatr Dis Treat. 2019 Jul 16;15:2003-2013. doi: 10.2147/NDT.S215277. eCollection 2019.

11.

A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.

Van Giau V, Pyun JM, Suh J, Bagyinszky E, An SSA, Kim SY.

BMC Neurol. 2019 Aug 7;19(1):188. doi: 10.1186/s12883-019-1419-y.

12.

Recent advances in the treatment of C. difficile using biotherapeutic agents.

Giau VV, Lee H, An SSA, Hulme J.

Infect Drug Resist. 2019 Jun 10;12:1597-1615. doi: 10.2147/IDR.S207572. eCollection 2019.

13.

Influenza mimetic protein-polymer nanoparticles as antigen delivery vehicles to dendritic cells for cancer immunotherapy.

Lee C, Jose L, Shim K, An SSA, Jang S, Song JK, Jin JO, Paik HJ.

Nanoscale. 2019 Aug 7;11(29):13878-13884. doi: 10.1039/c9nr03510a. Epub 2019 Jul 15.

PMID:
31304500
14.

Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases.

Park GY, Jamerlan A, Shim KH, An SSA.

Int J Mol Sci. 2019 Jun 18;20(12). pii: E2982. doi: 10.3390/ijms20122982. Review.

15.

Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.

Giau VV, Bagyinszky E, Yang YS, Youn YC, An SSA, Kim SY.

Sci Rep. 2019 Jun 10;9(1):8368. doi: 10.1038/s41598-019-44848-2.

16.

A microphysiological model of the bronchial airways reveals the interplay of mechanical and biochemical signals in bronchospasm.

Kilic O, Yoon A, Shah SR, Yong HM, Ruiz-Valls A, Chang H, Panettieri RA Jr, Liggett SB, Quiñones-Hinojosa A, An SS, Levchenko A.

Nat Biomed Eng. 2019 Jul;3(7):532-544. doi: 10.1038/s41551-019-0366-7. Epub 2019 Mar 11.

17.

Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.

Hughes RM, Simons BW, Khan H, Miller R, Kugler V, Torquato S, Theodros D, Haffner MC, Lotan T, Huang J, Davicioni E, An SS, Riddle RC, Thorek DLJ, Garraway IP, Fertig EJ, Isaacs JT, Brennen WN, Park BH, Hurley PJ.

Cancer Res. 2019 Jul 15;79(14):3636-3650. doi: 10.1158/0008-5472.CAN-18-2931. Epub 2019 May 23.

PMID:
31123087
18.

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer's disease.

Youn YC, Kang S, Suh J, Park YH, Kang MJ, Pyun JM, Choi SH, Jeong JH, Park KW, Lee HW, An SSA, Dominguez JC, Kim S.

Alzheimers Res Ther. 2019 May 10;11(1):40. doi: 10.1186/s13195-019-0499-7.

19.

Lysyl oxidase-like 2 depletion is protective in age-associated vascular stiffening.

Steppan J, Wang H, Bergman Y, Rauer MJ, Tan S, Jandu S, Nandakumar K, Barreto-Ortiz S, Cole RN, Boronina TN, Zhu W, Halushka MK, An SS, Berkowitz DE, Santhanam L.

Am J Physiol Heart Circ Physiol. 2019 Jul 1;317(1):H49-H59. doi: 10.1152/ajpheart.00670.2018. Epub 2019 Apr 19.

PMID:
31002285
20.

Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer's Disease.

Giau VV, Senanarong V, Bagyinszky E, An SSA, Kim S.

Int J Mol Sci. 2019 Mar 26;20(6). pii: E1514. doi: 10.3390/ijms20061514.

21.

A nonapoptotic endothelial barrier-protective role for caspase-3.

Suresh K, Carino K, Johnston L, Servinsky L, Machamer CE, Kolb TM, Lam H, Dudek SM, An SS, Rane MJ, Shimoda LA, Damarla M.

Am J Physiol Lung Cell Mol Physiol. 2019 Jun 1;316(6):L1118-L1126. doi: 10.1152/ajplung.00487.2018. Epub 2019 Mar 25.

PMID:
30908935
22.

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure.

Yang Y, Giau VV, An SSA, Kim S.

Dement Neurocogn Disord. 2018 Jun;17(2):41-49. doi: 10.12779/dnd.2018.17.2.41. Epub 2018 Jun 30.

23.

Transforming Growth Factor-β1 Decreases β2-Agonist-induced Relaxation in Human Airway Smooth Muscle.

Ojiaku CA, Chung E, Parikh V, Williams JK, Schwab A, Fuentes AL, Corpuz ML, Lui V, Paek S, Bexiga NM, Narayan S, Nunez FJ, Ahn K, Ostrom RS, An SS, Panettieri RA Jr.

Am J Respir Cell Mol Biol. 2019 Aug;61(2):209-218. doi: 10.1165/rcmb.2018-0301OC.

PMID:
30742476
24.

Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles.

Van Giau V, An SSA, Hulme J.

Drug Des Devel Ther. 2019 Jan 18;13:327-343. doi: 10.2147/DDDT.S190577. eCollection 2019. Review.

25.

Epitope Mapping Immunoassay Analysis of the Interaction between β-Amyloid and Fibrinogen.

Van Giau V, An SSA.

Int J Mol Sci. 2019 Jan 24;20(3). pii: E496. doi: 10.3390/ijms20030496.

26.

Pearls & Oy-sters: Challenging diagnosis of Gerstmann-Sträussler-Scheinker disease: Clinical and imaging findings.

Kang MJ, Suh J, An SS, Kim S, Park YH.

Neurology. 2019 Jan 8;92(2):101-103. doi: 10.1212/WNL.0000000000006730. No abstract available.

PMID:
30617168
27.

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease.

Van Giau V, Senanarong V, Bagyinszky E, Limwongse C, An SSA, Kim S.

Neuropsychiatr Dis Treat. 2018 Nov 8;14:3015-3023. doi: 10.2147/NDT.S180174. eCollection 2018.

28.

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.

Giau VV, Wu SY, Jamerlan A, An SSA, Kim SY, Hulme J.

Nutrients. 2018 Nov 14;10(11). pii: E1765. doi: 10.3390/nu10111765. Review.

29.

Mitochondrial therapeutic interventions in Alzheimer's disease.

Van Giau V, An SSA, Hulme JP.

J Neurol Sci. 2018 Dec 15;395:62-70. doi: 10.1016/j.jns.2018.09.033. Epub 2018 Sep 28. Review.

PMID:
30292965
30.

Orientation Controlled Protein Nanocapsules by Enzymatic Removal of a Polymer Template.

Lee C, Hwang A, Jose L, Park JH, Song JK, Shim K, An SSA, Paik HJ.

Biomacromolecules. 2018 Nov 12;19(11):4219-4227. doi: 10.1021/acs.biomac.8b00965. Epub 2018 Oct 12.

PMID:
30265806
31.

Biomechanical interplay between anisotropic re-organization of cells and the surrounding matrix underlies transition to invasive cancer spread.

Kim DH, Ewald AJ, Park J, Kshitiz, Kwak M, Gray RS, Su CY, Seo J, An SS, Levchenko A.

Sci Rep. 2018 Sep 21;8(1):14210. doi: 10.1038/s41598-018-32010-3.

32.

PSEN1 p.Thr116Ile Variant in Two Korean Families with Young Onset Alzheimer's Disease.

Bagyinszky E, Lee HM, Van Giau V, Koh SB, Jeong JH, An SSA, Kim S.

Int J Mol Sci. 2018 Sep 2;19(9). pii: E2604. doi: 10.3390/ijms19092604.

33.

[oil microbial biomass and enzyme activities among different artificial forests in Ziwuling, Northwest China.]

Bai XJ, Zeng QC, An SS, Zhang HX, Wang BR.

Ying Yong Sheng Tai Xue Bao. 2018 Aug;29(8):2695-2704. doi: 10.13287/j.1001-9332.201808.001. Chinese.

PMID:
30182610
34.

Novel PSEN1 p.Gly417Ala mutation in a Korean patient with early-onset Alzheimer's disease with parkinsonism.

Giau VV, Wang MJ, Bagyinszky E, Youn YC, An SSA, Kim S.

Neurobiol Aging. 2018 Dec;72:188.e13-188.e17. doi: 10.1016/j.neurobiolaging.2018.08.003. Epub 2018 Aug 9.

PMID:
30180983
35.

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S.

Neuropsychiatr Dis Treat. 2018 Aug 14;14:2067-2085. doi: 10.2147/NDT.S165445. eCollection 2018. Review.

36.

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer's disease.

Giau VV, Pyun JM, Bagyinszky E, An SSA, Kim S.

Clin Interv Aging. 2018 Jul 31;13:1321-1329. doi: 10.2147/CIA.S170374. eCollection 2018.

37.

Specific Targeting of MTAP-Deleted Tumors with a Combination of 2'-Fluoroadenine and 5'-Methylthioadenosine.

Tang B, Lee HO, An SS, Cai KQ, Kruger WD.

Cancer Res. 2018 Aug 1;78(15):4386-4395. doi: 10.1158/0008-5472.CAN-18-0814. Epub 2018 May 29.

38.

Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.

Tran AV, Shim K, Vo Thi TT, Kook JK, An SSA, Lee SW.

Acta Biomater. 2018 Jul 1;74:397-413. doi: 10.1016/j.actbio.2018.05.022. Epub 2018 May 21.

PMID:
29775731
39.

[Ecological stoichiometry of leaf and litter of herbaceous plants in loess hilly and gully regions, China].

Liu Y, Zeng QC, An SS, Li X, Huang YM.

Ying Yong Sheng Tai Xue Bao. 2017 Jun 18;28(6):1793-1800. doi: 10.13287/j.1001-9332.201706.036. Chinese.

PMID:
29745140
40.

[Effects of vegetation and topography features on ecological stoichiometry of soil and soil microbial biomass in the hilly-gully region of the Loess Plateau, China.]

Wang BR, Yang JJ, An SS, Zhang HX, Bai XJ.

Ying Yong Sheng Tai Xue Bao. 2018 Jan;29(1):247-259. doi: 10.13287/j.1001-9332.201801.039. Chinese.

PMID:
29692034
41.

Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation.

An SS, Henson CP, Freundlich RE, McEvoy MD.

Am J Transplant. 2018 Jun;18(6):1552-1555. doi: 10.1111/ajt.14736. Epub 2018 Apr 2.

42.

Desmin Phosphorylation Triggers Preamyloid Oligomers Formation and Myocyte Dysfunction in Acquired Heart Failure.

Rainer PP, Dong P, Sorge M, Fert-Bober J, Holewinski RJ, Wang Y, Foss CA, An SS, Baracca A, Solaini G, Glabe CG, Pomper MG, Van Eyk JE, Tomaselli GF, Paolocci N, Agnetti G.

Circ Res. 2018 May 11;122(10):e75-e83. doi: 10.1161/CIRCRESAHA.117.312082. Epub 2018 Feb 26.

43.

Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.

Giau VV, Lee H, Shim KH, Bagyinszky E, An SSA.

Clin Interv Aging. 2018 Feb 7;13:221-233. doi: 10.2147/CIA.S155145. eCollection 2018. Review.

44.

TGFβ1 reinforces arterial aging in the vascular smooth muscle cell through a long-range regulation of the cytoskeletal stiffness.

Zhu W, Kim BC, Wang M, Huang J, Isak A, Bexiga NM, Monticone R, Ha T, Lakatta EG, An SS.

Sci Rep. 2018 Feb 8;8(1):2668. doi: 10.1038/s41598-018-20763-w.

45.

Risk factors associated with open gingival embrasures after orthodontic treatment.

An SS, Choi YJ, Kim JY, Chung CJ, Kim KH.

Angle Orthod. 2018 May;88(3):267-274. doi: 10.2319/061917-399.12. Epub 2018 Jan 16.

PMID:
29337634
46.

Functional dissection of astrocyte-secreted proteins: Implications in brain health and diseases.

Jha MK, Kim JH, Song GJ, Lee WH, Lee IK, Lee HW, An SSA, Kim S, Suk K.

Prog Neurobiol. 2018 Mar;162:37-69. doi: 10.1016/j.pneurobio.2017.12.003. Epub 2017 Dec 13. Review.

PMID:
29247683
47.

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.

Wang MJ, Yi S, Han JY, Park SY, Jang JW, Chun IK, Kim SE, Lee BS, Kim GJ, Yu JS, Lim K, Kang SM, Park YH, Youn YC, An SSA, Kim S.

Alzheimers Res Ther. 2017 Dec 15;9(1):98. doi: 10.1186/s13195-017-0324-0.

48.

Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines.

Pera T, Deshpande DA, Ippolito M, Wang B, Gavrila A, Michael JV, Nayak AP, Tompkins E, Farrell E, Kroeze WK, Roth BL, Panettieri RA Jr, Benovic JL, An SS, Dulin NO, Penn RB.

FASEB J. 2018 Feb;32(2):862-874. doi: 10.1096/fj.201700555R. Epub 2018 Jan 4.

49.

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42.

An SSA, Lee BS, Yu JS, Lim K, Kim GJ, Lee R, Kim S, Kang S, Park YH, Wang MJ, Yang YS, Youn YC, Kim S.

Alzheimers Res Ther. 2017 Oct 17;9(1):86. doi: 10.1186/s13195-017-0310-6.

50.

TGF-β1 Evokes Human Airway Smooth Muscle Cell Shortening and Hyperresponsiveness via Smad3.

Ojiaku CA, Cao G, Zhu W, Yoo EJ, Shumyatcher M, Himes BE, An SS, Panettieri RA Jr.

Am J Respir Cell Mol Biol. 2018 May;58(5):575-584. doi: 10.1165/rcmb.2017-0247OC.

Supplemental Content

Support Center